...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Risk factors of occult malignancy in patients with unprovoked venous thromboembolism
【24h】

Risk factors of occult malignancy in patients with unprovoked venous thromboembolism

机译:未加工静脉血栓栓塞患者潜水恶性肿瘤的危险因素

获取原文
获取原文并翻译 | 示例

摘要

Abstract Venous thromboembolism (VTE) can occur as the first manifestation of an underlying occult malignancy. It remains unclear whether or not a better selection of high risk patients might lead to more efficient occult cancer screening strategies. Our aim was to assess the predictors of occult malignancy diagnosis in patients with unprovoked VTE. Univariate analyses were performed to assess the effect of candidate predictors on occult cancer detection in patients enrolled in a prospective, multicenter, randomized, controlled study (MVTEP study) whose primary aim was to compare a limited screening strategy with a strategy combining limited screening and FDG PET/CT in patients with unprovoked VTE. This trial is completed and registered with ClinicalTrials.gov , number NCT00964275 . Between March 3, 2009, and August 18, 2012, 399 patients were included. Five patients withdrew consent and refused the use of their data, and no VTE was confirmed in 2 patients who were excluded from this analysis. A total of 25 (6.4%) out of the 392 analysed patients received a new diagnosis of malignancyduring the 2-years follow-up. Age≥50years ( p =0.01), male gender ( p =0.04), leukocytes count (p=0.01), and platelets count ( p =0.03) were associated with occult cancer detection. Patients with leukocytosis or thrombocytosis had a risk of cancer way above 10%. Previous VTE and smoker status (combining previous and current smokers) were not associated with occult cancer diagnosis ( p >0.05). Demographic characteristics (age and sex), and laboratory tests (high platelets and leukocytes counts) may be associated with cancer detection in patients withunprovoked VTE. Highlights ? Venous thromboembolism can occur as the first manifestation of an occult malignancy. ? Selecting “high risk” patients might lead to more efficient occult cancer screening strategies. ? Age≥50 y, male sex, high platelets and leukocytes counts may be associated with cancer detection. ? Previous VTE and smoker status were not associated with occult cancer diagnosis .
机译:摘要静脉血栓栓塞(VTE)可作为潜在的隐匿性恶性肿瘤的第一个表现。目前尚不清楚更好地选择高危患者是否会导致更有效的隐匿性癌症筛查策略。我们的目的是评估不明原因VTE患者隐匿性恶性肿瘤诊断的预测因子。在一项前瞻性、多中心、随机、对照研究(MVTEP研究)中,对入选患者进行单变量分析,以评估候选预测因子对隐匿性癌症检测的影响,该研究的主要目的是比较有限筛查策略与结合有限筛查和FDG PET/CT的策略对无故VTE患者的影响。该试验已完成,并在临床试验中心登记。政府,电话:NCT00964275。从2009年3月3日到2012年8月18日,共有399名患者被纳入研究。5名患者撤回同意并拒绝使用他们的数据,2名被排除在本分析之外的患者未确认VTE。在392例分析患者中,共有25例(6.4%)在2年的随访中获得了新的恶性诊断。年龄≥50岁(p=0.01)、男性(p=0.04)、白细胞计数(p=0.01)和血小板计数(p=0.03)与隐匿性癌症检测相关。白细胞增多症或血小板增多症患者患癌症的风险超过10%。既往VTE和吸烟者状态(结合既往和当前吸烟者)与隐匿性癌症诊断无关(p>0.05)。人口统计学特征(年龄和性别)和实验室检查(高血小板和白细胞计数)可能与无故VTE患者的癌症检测相关。亮点?静脉血栓栓塞可作为隐匿性恶性肿瘤的第一个表现?选择“高危”患者可能会导致更有效的隐匿性癌症筛查策略?年龄≥50岁、男性、高血小板和白细胞计数可能与癌症检测有关?既往VTE和吸烟者状态与隐匿性癌症诊断无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号